Molecular genetic diagnostics: Technology for detecting mutations in DNA;Molekylsergenetisk diagnostikk: Teknologi for påvisning av mutasjoner i DNA

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 11, 1998, Pages 1730-1736

  Eiken, Hans Geir ^a   Børresen Dale, Anne Lise ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MEDICAL GENETICS; METHODOLOGY; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVIEW;

COST-BENEFIT ANALYSIS; DNA MUTATIONAL ANALYSIS; GENETICS, MEDICAL; HUMANS; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION;

EID: 0032580113     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Chang JC, Kan YW. A sensitive new prenatal test for sickle-cell anemia. N Engl J Med 1982; 307: 30-2.
2. Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CHCM et al. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 1995; 4: 821-30.
3. + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995; 92: 3381-6.
4. Børresen AL. Genteknologi i klinisk medisin - teknikker og verktøy. Tidsskr Nor Lægeforen 1989, 109: 2882-7.
5. Børresen AL, Berg K. Genetisk variasjon og genetiske sykdommer. Tidsskr Nor Lasgeforen 1989; 109: 3003-9.
6. Kristensen T. Genteknologi i klinisk medisin - DNA-sekvensering. Tidsskr Nor Lægeforen 1989; 109: 2887-9.
7. Koonin SE. An independent perspective on the human genome project. Science 1998; 279: 36-7.
8. Leren TP, Bakken KS, Rodningen OK, Gundersen KE, Sundvold H, Berg K et al. Genteknologisk diagnostikk av familiær hyperkolesterolemi. Tidsskr Nor Lægeforen 1997; 117: 678-81.
9. Eiken HG, Knappskog PM, Boman H, Thune KS, Kaada G, Motzfeldt K et al. Relative frequency, heterogeneiety and geographic clustering of PKU mutations in Norway. Eur J Hum Genet 1996; 4: 205-13.
10. Breast Cancer Information Core (BIC) data base: http://www.nchgr.nih.gov/dir/lab-transfer/ bic/.
11. Eiklid K, Tranebjærg L, Eiken HG, Pedersen JC, Michaelsen H, Fluge G et al. Frequency of the AF508 and exon 11 mutations in Norwegian cystic fibrosis patients. Clin Genet 1993; 44: 12-4.
12. Eiken HG, Boman H, Apold J. DNA-diagnostikk ved fragil X-syndrom i ein familie. Eit dome på ein ny type arvegang - dynamiske mutasjonar. Tidsskr Nor Lægeforen 1993; 113: 3236-9.
13. Cotton RGH. Slowly but surely towards better scanning for mutations. Trends Genet 1997; 13: 43-6.
14. Kleppe K, Ohtsuka E, Kleppe R, Molineux L, Khorana HG. Studies on polynucleotides XCVI: repair replications of short syntetic DNAs as catalysed by DNA polymerases. J Mol Biol 1971; 56: 341-61.
15. Saiki RK, Sharf SJ, Faloona F, Mullis KB, Horn GT, Erlich HA et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 239: 487-91.
16. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997; 17: 341-5.
17. Olsen T, Eiken HG, Knappskog PM, Kase BF, Månsson JE, Boman H et al. Mutations in the iduronat-2-sulfatase gene in five Norwegians with Hunter syndrome. Hum Genet 1996; 97: 198-203.
18. Cotton RGH, Rodrigues NR, Campbell RD. Reactivity of cytosine and thymine in single base-pair mismatches with hydroxylamine and osmium tetraoxide and its application to the study of mutations. Proc Natl Acad Sci USA 1988; 85: 4397-401.
19. Forrest SM, Dahl HH, Howells DW, Dianzani I, Cotton RGH. Mutation detection in phenylketonuria by using chemical cleavage of mismatch: importance of using probes from both normal and patient. Am J Hum Genet 1991; 49: 175-83.
20. Condie A, Eeles R, Børresen AL, Coles C, Cooper C, Prosser J. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum Mutat 1993; 2: 58-66.
21. Sarkar G, Yoon H, Sommer SS. Dideoxy fingerprinting (ddF): a rapid and efficient screen for the presence of mutations. Genomics 1992; 13: 441-3.
22. Liu Q, Sommer SS. Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP. PCR Methods Appl 1994; 4: 97-108.
23. Gyllensten UB, Ehrlich HA. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 1988; 85: 7652-6.
24. Kwok P-Y, Carlson C, Yager TD, Akener W, Nickerson DA. Comparative analysis of human DNA variations by fluorescence-based sequencing of PCR-products. Genomics 1994; 23: 138-44.
25. Fisher SG, Lerman LS. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA 1983; 87: 2092-6.
26. Guldberg P, Güttler F. «Broad-range» DGGE for single-step mutation scanning of entire genes: application to human phenylalanine hydroxylasc gene. Nucleic Acids Res 1994; 22: 880-1.
27. Borresen AL. Constant dénaturant gel electrophoresis (CDGE) in mutation screening II. I: Pfeifer GP, red. Technologies for detection of DNA damage and mutations. New York: Plenum Press, 1996: 267-79.
28. Hovig E, Smith-Sørensen B, Brøgger A, Børresen AL. Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection. Mutat Res 1991; 262: 63-71.
29. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
30. Jordanova A, Kalaydjieva L, Savov A, Claustres M, Schwarz M, Estivill X et al. SSCP analysis: ablind senstivity trial. Hum Mutat 1997; 10: 65-70.
31. Liu Q, Sommer SS. Restriction endonuclease fingerprinting (REF): a sensitive method for. screening mutations in long, contiguous segments of DNA. BioTechniques 1995; 18: 470-7.
32. 32P-SSCP sensitivity by combining RE digestion and extended X-ray film exposures. Biotechniques 1997; 22: 598-602
33. Roest PAM, Roberts RG, Sugino S, van Ommen GJB, den Dunnen JT. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet 1993; 2: 1719-21.
34. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM et al. Molecular diagnosis of familiar adenomatous polyposis. N Engl J Med 1993; 329: 1982-7.
35. Hacia JG, Brody LC, Chee MS, Fodor SPA, Collins FS. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet 1996; 14: 441-7.
36. Breivik J, Lothe RA, Meling GI, Rognum PO, Børresen-Dale AL, Gaudemack G. Different genetic pathways to proximal and distal colorectal cancer influenced by sex related factors. Int J Cancer 1997; 74: 664-9.
37. van Orsouw NJ, Li D, van der Vlies P, Scheffer H, Eng C, Buys CHCM et al. Mutational scanning of large genes by extensive PCR multiplexing and two-dimensional electrophoresis: application to the RB1 gene. Hum Mol Genet 1996; 5: 755-61.
38. Eng C, Vijg J. Genetic testing: The problems and the promise. Nat Biotechnol 1997; 15: 422-6.
39. Wall J, Cai S, Chehab FF. A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum Mutat 1995; 5: 333-8.
40. Takeda S, Ichii S, Nakamura Y. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum Mutat 1993; 2: 112-7.
41. Barany F. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci USA 1991; 88: 189-93.
42. Eiken HG, Odland E, Boman H, Skjelkvåle L, Engebretsen LF, Apold J. Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Res 1991; 19: 1427-30.
43. Leren TP, Rodningen OK, Røsby O, Solberg K, Berg K. Screening for point mutations by semi-automated DNA sequencing using sequenase and magenetic beads. Biotechniques 1993, 14: 618-23.
44. Ellingsen S, Knappskog PM, Eiken HG. Phenylketonuria splice mutation (EXON 6nt-96A > g) masquerading as missense mutation (Y204C). Hum Mutat 1997; 9: 88-90.
45. Liu W, Qian C, Francke U. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet 1997; 16: 328-9.